These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11713378)

  • 21. [Chronic myeloid leukemia onset with marked thrombocythemia].
    Shen Q; Zhou JW; Zhu GR; Yang YY; Qiu HR; Zhu GR; Xia W; Jiang PJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):247-51. PubMed ID: 16638190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview].
    Campr V
    Cesk Patol; 2011 Jul; 47(3):84-93. PubMed ID: 21887923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].
    Brière J
    Bull Acad Natl Med; 2007 Mar; 191(3):535-48. PubMed ID: 18072652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.
    Michiels JJ
    Hematol J; 2004; 5(2):93-102. PubMed ID: 15048058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Successful low-dose etoposide therapy for a case of myelofibrosis with chronic myelogenous leukemia megakaryocytic predominance type].
    Katayama T; Masuoka H; Yoshida M; Watanabe R; Nishiwaki K; Shimada T; Kaito K; Ochiai S; Kobayashi M; Sakai O
    Rinsho Ketsueki; 1992 Apr; 33(4):488-93. PubMed ID: 1602613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Granulopoiesis and cytogenetic studies in chronic myeloid leukemia: their correlation with the clinical stage of the disease].
    Bianchi de Di Risio CC; Labal de Vinuesa ML; Fernández J; Gronda M; Larripa I
    Sangre (Barc); 1988 Jun; 33(3):178-83. PubMed ID: 3175814
    [No Abstract]   [Full Text] [Related]  

  • 28. MPN blast phase: clinical challenge and assessing response.
    Mesa RA; Tibes R
    Leuk Res; 2012 Dec; 36(12):1496-7. PubMed ID: 22999527
    [No Abstract]   [Full Text] [Related]  

  • 29. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of megakaryoblastic leukemia showing features like primary myelofibrosis].
    Takizawa S; Sanada M; Tsukada T; Koike T; Shibata A
    Rinsho Ketsueki; 1984 Dec; 25(12):1967-72. PubMed ID: 6543457
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histological and clinical evolution patterns of chronic myelocytic leukemia.
    Varma N; Varma S; Marwaha N; Garewal G
    Indian J Cancer; 1997 Dec; 34(4):164-8. PubMed ID: 9715539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blast transformation in chronic myeloid leukemia with synovial involvement.
    Li CY; Yam LT
    Acta Cytol; 1991; 35(5):543-5. PubMed ID: 1927195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transformation of Waldenström disease into chronic myeloid leukemia].
    Bonanni G; D'Ambrosio F; Marino S; Sindici G; Ieraci A; D'Artista D
    Recenti Prog Med; 1999 Oct; 90(10):527-9. PubMed ID: 10592738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic-granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders.
    Lichtman MA
    Leukemia; 2005 Jul; 19(7):1139-41. PubMed ID: 15902283
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical characteristics of the blast phase of chronic granulocytic leukemia.
    Canellos GP
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):359-67. PubMed ID: 2182596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Myeloproliferative disorders].
    Binder D; Fehr J
    Ther Umsch; 2004 Feb; 61(2):131-42. PubMed ID: 15018396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis.
    Brousseau M; Parot-Schinkel E; Moles MP; Boyer F; Hunault M; Rousselet MC
    Histopathology; 2010 May; 56(6):758-67. PubMed ID: 20546341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia.
    Muth M; Engelhardt BM; Kröger N; Hussein K; Schlué J; Büsche G; Kreipe HH; Bock O
    Ann Hematol; 2011 Jan; 90(1):33-40. PubMed ID: 20625903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells.
    Crescenzi B; Chase A; Starza RL; Beacci D; Rosti V; Gallì A; Specchia G; Martelli MF; Vandenberghe P; Cools J; Jones AV; Cross NC; Marynen P; Mecucci C
    Leukemia; 2007 Mar; 21(3):397-402. PubMed ID: 17215855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.